nodes	percent_of_prediction	percent_of_DWPC	metapath
Leflunomide—CYP2C9—Disulfiram—alcohol dependence	0.188	0.558	CbGbCtD
Leflunomide—CYP1A2—Citalopram—alcohol dependence	0.149	0.442	CbGbCtD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—ALDH3A1—alcohol dependence	0.0138	0.106	CbGpPWpGaD
Leflunomide—ABCG2—Abacavir transport and metabolism—ADH1A—alcohol dependence	0.0106	0.0821	CbGpPWpGaD
Leflunomide—DHODH—gonad—alcohol dependence	0.00658	0.0564	CbGeAlD
Leflunomide—DHODH—blood—alcohol dependence	0.00574	0.0491	CbGeAlD
Leflunomide—PTK2B—forebrain—alcohol dependence	0.00543	0.0466	CbGeAlD
Leflunomide—DHODH—endocrine gland—alcohol dependence	0.00497	0.0426	CbGeAlD
Leflunomide—PTK2B—Alpha-synuclein signaling—MAOB—alcohol dependence	0.00485	0.0375	CbGpPWpGaD
Leflunomide—DHODH—testis—alcohol dependence	0.00474	0.0406	CbGeAlD
Leflunomide—PTK2B—cardiovascular system—alcohol dependence	0.00459	0.0394	CbGeAlD
Leflunomide—DHODH—liver—alcohol dependence	0.00449	0.0384	CbGeAlD
Leflunomide—PTK2B—gonad—alcohol dependence	0.00417	0.0357	CbGeAlD
Leflunomide—AHR—adrenal cortex—alcohol dependence	0.00414	0.0355	CbGeAlD
Leflunomide—PTK2B—digestive system—alcohol dependence	0.00381	0.0327	CbGeAlD
Leflunomide—CYP1A2—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.0038	0.0294	CbGpPWpGaD
Leflunomide—AHR—pancreas—alcohol dependence	0.00367	0.0315	CbGeAlD
Leflunomide—PTK2B—blood—alcohol dependence	0.00363	0.0311	CbGeAlD
Leflunomide—DHODH—brain—alcohol dependence	0.00356	0.0305	CbGeAlD
Leflunomide—PTK2B—Alpha-synuclein signaling—SLC6A3—alcohol dependence	0.00321	0.0249	CbGpPWpGaD
Leflunomide—PTK2B—endocrine gland—alcohol dependence	0.00315	0.027	CbGeAlD
Leflunomide—CYP1A2—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00315	0.0243	CbGpPWpGaD
Leflunomide—AHR—digestive system—alcohol dependence	0.00314	0.0269	CbGeAlD
Leflunomide—PTK2B—testis—alcohol dependence	0.00301	0.0258	CbGeAlD
Leflunomide—AHR—blood—alcohol dependence	0.00299	0.0256	CbGeAlD
Leflunomide—PTK2B—nervous system—alcohol dependence	0.00295	0.0253	CbGeAlD
Leflunomide—AHR—midbrain—alcohol dependence	0.00295	0.0253	CbGeAlD
Leflunomide—PTK2B—liver—alcohol dependence	0.00284	0.0243	CbGeAlD
Leflunomide—PTK2B—central nervous system—alcohol dependence	0.00284	0.0243	CbGeAlD
Leflunomide—PTK2B—cerebellum—alcohol dependence	0.00278	0.0238	CbGeAlD
Leflunomide—CYP1A2—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00267	0.0207	CbGpPWpGaD
Leflunomide—AHR—endocrine gland—alcohol dependence	0.00259	0.0222	CbGeAlD
Leflunomide—AHR—testis—alcohol dependence	0.00247	0.0212	CbGeAlD
Leflunomide—AHR—liver—alcohol dependence	0.00234	0.02	CbGeAlD
Leflunomide—AHR—cerebellum—alcohol dependence	0.00228	0.0196	CbGeAlD
Leflunomide—CYP1A2—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00227	0.0176	CbGpPWpGaD
Leflunomide—PTK2B—brain—alcohol dependence	0.00225	0.0193	CbGeAlD
Leflunomide—CYP1A2—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.002	0.0155	CbGpPWpGaD
Leflunomide—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00199	0.0154	CbGpPWpGaD
Leflunomide—CYP1A2—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.0019	0.0147	CbGpPWpGaD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—WASF2—alcohol dependence	0.00188	0.0145	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—OPRM1—alcohol dependence	0.00186	0.0144	CbGpPWpGaD
Leflunomide—AHR—brain—alcohol dependence	0.00185	0.0159	CbGeAlD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—WASF1—alcohol dependence	0.0018	0.0139	CbGpPWpGaD
Leflunomide—CYP2C9—CYP2E1 reactions—CYP2E1—alcohol dependence	0.00177	0.0137	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by VEGF—WASF2—alcohol dependence	0.00177	0.0137	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by VEGF—WASF1—alcohol dependence	0.0017	0.0131	CbGpPWpGaD
Leflunomide—ABCG2—adrenal cortex—alcohol dependence	0.00161	0.0138	CbGeAlD
Leflunomide—AHR—Circadian rythm related genes—CRH—alcohol dependence	0.00158	0.0123	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	0.00156	0.012	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	0.00156	0.012	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—ALDH3A1—alcohol dependence	0.00152	0.0117	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—SLC6A4—alcohol dependence	0.00147	0.0114	CbGpPWpGaD
Leflunomide—CYP1A2—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.0014	0.0109	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—ADH6—alcohol dependence	0.00139	0.0108	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—DRD4—alcohol dependence	0.00138	0.0107	CbGpPWpGaD
Leflunomide—CYP2C9—cardiovascular system—alcohol dependence	0.00134	0.0115	CbGeAlD
Leflunomide—AHR—Circadian rythm related genes—HTR7—alcohol dependence	0.00129	0.00998	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—DRD2—alcohol dependence	0.00129	0.00998	CbGpPWpGaD
Leflunomide—CYP2C9—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00125	0.00968	CbGpPWpGaD
Leflunomide—CYP1A2—digestive system—alcohol dependence	0.00117	0.01	CbGeAlD
Leflunomide—ABCG2—blood—alcohol dependence	0.00116	0.00993	CbGeAlD
Leflunomide—DHODH—Metabolism—ADH1A—alcohol dependence	0.00115	0.00891	CbGpPWpGaD
Leflunomide—ABCG2—midbrain—alcohol dependence	0.00114	0.0098	CbGeAlD
Leflunomide—CYP1A2—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.00112	0.00869	CbGpPWpGaD
Leflunomide—CYP1A2—blood—alcohol dependence	0.00112	0.00955	CbGeAlD
Leflunomide—CYP2C9—digestive system—alcohol dependence	0.00111	0.00952	CbGeAlD
Leflunomide—CYP2C9—Xenobiotics—CYP2E1—alcohol dependence	0.0011	0.00851	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—AVP—alcohol dependence	0.00109	0.0084	CbGpPWpGaD
Leflunomide—CYP1A2—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00107	0.00827	CbGpPWpGaD
Leflunomide—CYP2C9—blood—alcohol dependence	0.00106	0.00907	CbGeAlD
Leflunomide—CYP2C9—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00106	0.00818	CbGpPWpGaD
Leflunomide—Sepsis—Citalopram—alcohol dependence	0.00105	0.00252	CcSEcCtD
Leflunomide—Asthenia—Disulfiram—alcohol dependence	0.00105	0.00252	CcSEcCtD
Leflunomide—Conjunctivitis—Naltrexone—alcohol dependence	0.00104	0.00249	CcSEcCtD
Leflunomide—Urinary tract infection—Naltrexone—alcohol dependence	0.00104	0.00249	CcSEcCtD
Leflunomide—CYP2C9—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00104	0.00802	CbGpPWpGaD
Leflunomide—Lymphadenopathy—Citalopram—alcohol dependence	0.00103	0.00247	CcSEcCtD
Leflunomide—Haemoglobin—Acamprosate—alcohol dependence	0.00102	0.00244	CcSEcCtD
Leflunomide—Rhinitis—Acamprosate—alcohol dependence	0.00102	0.00244	CcSEcCtD
Leflunomide—Sleep disorder—Citalopram—alcohol dependence	0.00101	0.00244	CcSEcCtD
Leflunomide—Haemorrhage—Acamprosate—alcohol dependence	0.00101	0.00243	CcSEcCtD
Leflunomide—Hepatitis—Acamprosate—alcohol dependence	0.00101	0.00243	CcSEcCtD
Leflunomide—Hepatobiliary disease—Naltrexone—alcohol dependence	0.00101	0.00242	CcSEcCtD
Leflunomide—Diabetes mellitus—Citalopram—alcohol dependence	0.00101	0.00242	CcSEcCtD
Leflunomide—Epistaxis—Naltrexone—alcohol dependence	0.00101	0.00242	CcSEcCtD
Leflunomide—Pharyngitis—Acamprosate—alcohol dependence	0.00101	0.00241	CcSEcCtD
Leflunomide—Sinusitis—Naltrexone—alcohol dependence	0.001	0.00241	CcSEcCtD
Leflunomide—Oedema peripheral—Acamprosate—alcohol dependence	0.000999	0.0024	CcSEcCtD
Leflunomide—Gastroenteritis—Citalopram—alcohol dependence	0.000991	0.00238	CcSEcCtD
Leflunomide—DHODH—Metabolism—ADH4—alcohol dependence	0.00098	0.00758	CbGpPWpGaD
Leflunomide—Eczema—Citalopram—alcohol dependence	0.000978	0.00235	CcSEcCtD
Leflunomide—Hepatic failure—Citalopram—alcohol dependence	0.000978	0.00235	CcSEcCtD
Leflunomide—CYP1A2—endocrine gland—alcohol dependence	0.000967	0.00829	CbGeAlD
Leflunomide—Dizziness—Disulfiram—alcohol dependence	0.000967	0.00232	CcSEcCtD
Leflunomide—Hepatitis—Naltrexone—alcohol dependence	0.000959	0.0023	CcSEcCtD
Leflunomide—ABCG2—testis—alcohol dependence	0.000958	0.00821	CbGeAlD
Leflunomide—PTK2B—BDNF signaling pathway—GRIN2B—alcohol dependence	0.000954	0.00738	CbGpPWpGaD
Leflunomide—Pharyngitis—Naltrexone—alcohol dependence	0.000952	0.00228	CcSEcCtD
Leflunomide—PTK2B—BDNF signaling pathway—CNR1—alcohol dependence	0.000947	0.00733	CbGpPWpGaD
Leflunomide—Connective tissue disorder—Naltrexone—alcohol dependence	0.000943	0.00226	CcSEcCtD
Leflunomide—CYP1A2—Xenobiotics—CYP2E1—alcohol dependence	0.000939	0.00727	CbGpPWpGaD
Leflunomide—Rash—Disulfiram—alcohol dependence	0.000922	0.00221	CcSEcCtD
Leflunomide—CYP2C9—endocrine gland—alcohol dependence	0.000918	0.00787	CbGeAlD
Leflunomide—Headache—Disulfiram—alcohol dependence	0.000916	0.0022	CcSEcCtD
Leflunomide—Immune system disorder—Acamprosate—alcohol dependence	0.000916	0.0022	CcSEcCtD
Leflunomide—Chills—Acamprosate—alcohol dependence	0.00091	0.00218	CcSEcCtD
Leflunomide—ABCG2—liver—alcohol dependence	0.000906	0.00776	CbGeAlD
Leflunomide—Arthritis—Citalopram—alcohol dependence	0.000904	0.00217	CcSEcCtD
Leflunomide—CYP1A2—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000904	0.00699	CbGpPWpGaD
Leflunomide—CYP1A2—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000899	0.00695	CbGpPWpGaD
Leflunomide—Eye disorder—Naltrexone—alcohol dependence	0.000896	0.00215	CcSEcCtD
Leflunomide—Alopecia—Acamprosate—alcohol dependence	0.000896	0.00215	CcSEcCtD
Leflunomide—Cardiac disorder—Naltrexone—alcohol dependence	0.00089	0.00214	CcSEcCtD
Leflunomide—Mental disorder—Acamprosate—alcohol dependence	0.000888	0.00213	CcSEcCtD
Leflunomide—CYP1A2—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000886	0.00685	CbGpPWpGaD
Leflunomide—ABCG2—cerebellum—alcohol dependence	0.000885	0.00758	CbGeAlD
Leflunomide—Malnutrition—Acamprosate—alcohol dependence	0.000883	0.00212	CcSEcCtD
Leflunomide—CYP2C9—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000881	0.00682	CbGpPWpGaD
Leflunomide—Osteoarthritis—Citalopram—alcohol dependence	0.000879	0.00211	CcSEcCtD
Leflunomide—CYP1A2—liver—alcohol dependence	0.000872	0.00747	CbGeAlD
Leflunomide—Flatulence—Acamprosate—alcohol dependence	0.00087	0.00209	CcSEcCtD
Leflunomide—Immune system disorder—Naltrexone—alcohol dependence	0.000866	0.00208	CcSEcCtD
Leflunomide—Migraine—Citalopram—alcohol dependence	0.000865	0.00207	CcSEcCtD
Leflunomide—Mediastinal disorder—Naltrexone—alcohol dependence	0.000864	0.00207	CcSEcCtD
Leflunomide—Dysgeusia—Acamprosate—alcohol dependence	0.000864	0.00207	CcSEcCtD
Leflunomide—Chills—Naltrexone—alcohol dependence	0.000861	0.00207	CcSEcCtD
Leflunomide—Back pain—Acamprosate—alcohol dependence	0.000854	0.00205	CcSEcCtD
Leflunomide—Muscle spasms—Acamprosate—alcohol dependence	0.000849	0.00204	CcSEcCtD
Leflunomide—Alopecia—Naltrexone—alcohol dependence	0.000848	0.00203	CcSEcCtD
Leflunomide—Mental disorder—Naltrexone—alcohol dependence	0.00084	0.00202	CcSEcCtD
Leflunomide—Malnutrition—Naltrexone—alcohol dependence	0.000835	0.002	CcSEcCtD
Leflunomide—DHODH—Metabolism—ADH7—alcohol dependence	0.000833	0.00645	CbGpPWpGaD
Leflunomide—CYP2C9—liver—alcohol dependence	0.000828	0.00709	CbGeAlD
Leflunomide—Flatulence—Naltrexone—alcohol dependence	0.000823	0.00197	CcSEcCtD
Leflunomide—Ill-defined disorder—Acamprosate—alcohol dependence	0.000819	0.00196	CcSEcCtD
Leflunomide—Dysgeusia—Naltrexone—alcohol dependence	0.000818	0.00196	CcSEcCtD
Leflunomide—Anaemia—Acamprosate—alcohol dependence	0.000816	0.00196	CcSEcCtD
Leflunomide—Liver function test abnormal—Citalopram—alcohol dependence	0.000811	0.00195	CcSEcCtD
Leflunomide—Back pain—Naltrexone—alcohol dependence	0.000808	0.00194	CcSEcCtD
Leflunomide—Angioedema—Acamprosate—alcohol dependence	0.000806	0.00193	CcSEcCtD
Leflunomide—Dry skin—Citalopram—alcohol dependence	0.000805	0.00193	CcSEcCtD
Leflunomide—Muscle spasms—Naltrexone—alcohol dependence	0.000803	0.00193	CcSEcCtD
Leflunomide—Hypokalaemia—Citalopram—alcohol dependence	0.0008	0.00192	CcSEcCtD
Leflunomide—DHODH—Metabolism—GGT2—alcohol dependence	0.000799	0.00618	CbGpPWpGaD
Leflunomide—Malaise—Acamprosate—alcohol dependence	0.000796	0.00191	CcSEcCtD
Leflunomide—Breast disorder—Citalopram—alcohol dependence	0.000794	0.0019	CcSEcCtD
Leflunomide—Vertigo—Acamprosate—alcohol dependence	0.000793	0.0019	CcSEcCtD
Leflunomide—Cramp muscle—Citalopram—alcohol dependence	0.000791	0.0019	CcSEcCtD
Leflunomide—Toxic epidermal necrolysis—Citalopram—alcohol dependence	0.000791	0.0019	CcSEcCtD
Leflunomide—Leukopenia—Acamprosate—alcohol dependence	0.00079	0.0019	CcSEcCtD
Leflunomide—Vision blurred—Naltrexone—alcohol dependence	0.000787	0.00189	CcSEcCtD
Leflunomide—Palpitations—Acamprosate—alcohol dependence	0.00078	0.00187	CcSEcCtD
Leflunomide—Gastritis—Citalopram—alcohol dependence	0.000778	0.00187	CcSEcCtD
Leflunomide—Ill-defined disorder—Naltrexone—alcohol dependence	0.000775	0.00186	CcSEcCtD
Leflunomide—Cough—Acamprosate—alcohol dependence	0.00077	0.00185	CcSEcCtD
Leflunomide—Angioedema—Naltrexone—alcohol dependence	0.000763	0.00183	CcSEcCtD
Leflunomide—Hypertension—Acamprosate—alcohol dependence	0.000762	0.00183	CcSEcCtD
Leflunomide—Asthma—Citalopram—alcohol dependence	0.000759	0.00182	CcSEcCtD
Leflunomide—Influenza—Citalopram—alcohol dependence	0.000759	0.00182	CcSEcCtD
Leflunomide—CYP1A2—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000753	0.00583	CbGpPWpGaD
Leflunomide—Malaise—Naltrexone—alcohol dependence	0.000753	0.00181	CcSEcCtD
Leflunomide—Eosinophilia—Citalopram—alcohol dependence	0.000752	0.0018	CcSEcCtD
Leflunomide—Myalgia—Acamprosate—alcohol dependence	0.000751	0.0018	CcSEcCtD
Leflunomide—Chest pain—Acamprosate—alcohol dependence	0.000751	0.0018	CcSEcCtD
Leflunomide—Arthralgia—Acamprosate—alcohol dependence	0.000751	0.0018	CcSEcCtD
Leflunomide—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000749	0.0058	CbGpPWpGaD
Leflunomide—Anxiety—Acamprosate—alcohol dependence	0.000749	0.0018	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000746	0.00179	CcSEcCtD
Leflunomide—Pancreatitis—Citalopram—alcohol dependence	0.000744	0.00179	CcSEcCtD
Leflunomide—Discomfort—Acamprosate—alcohol dependence	0.000742	0.00178	CcSEcCtD
Leflunomide—Sweating increased—Citalopram—alcohol dependence	0.00074	0.00177	CcSEcCtD
Leflunomide—Angina pectoris—Citalopram—alcohol dependence	0.00074	0.00177	CcSEcCtD
Leflunomide—Palpitations—Naltrexone—alcohol dependence	0.000738	0.00177	CcSEcCtD
Leflunomide—Dry mouth—Acamprosate—alcohol dependence	0.000735	0.00176	CcSEcCtD
Leflunomide—DHODH—Metabolism—ADH1B—alcohol dependence	0.00073	0.00565	CbGpPWpGaD
Leflunomide—Bronchitis—Citalopram—alcohol dependence	0.00073	0.00175	CcSEcCtD
Leflunomide—Cough—Naltrexone—alcohol dependence	0.000729	0.00175	CcSEcCtD
Leflunomide—Pancytopenia—Citalopram—alcohol dependence	0.000721	0.00173	CcSEcCtD
Leflunomide—Hypertension—Naltrexone—alcohol dependence	0.000721	0.00173	CcSEcCtD
Leflunomide—Anaphylactic shock—Acamprosate—alcohol dependence	0.00072	0.00173	CcSEcCtD
Leflunomide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000719	0.00556	CbGpPWpGaD
Leflunomide—ABCG2—brain—alcohol dependence	0.000719	0.00616	CbGeAlD
Leflunomide—Infection—Acamprosate—alcohol dependence	0.000716	0.00172	CcSEcCtD
Leflunomide—Chest pain—Naltrexone—alcohol dependence	0.000711	0.00171	CcSEcCtD
Leflunomide—Myalgia—Naltrexone—alcohol dependence	0.000711	0.00171	CcSEcCtD
Leflunomide—Arthralgia—Naltrexone—alcohol dependence	0.000711	0.00171	CcSEcCtD
Leflunomide—Dysuria—Citalopram—alcohol dependence	0.00071	0.0017	CcSEcCtD
Leflunomide—CYP1A2—Tryptophan metabolism—MAOB—alcohol dependence	0.00071	0.00549	CbGpPWpGaD
Leflunomide—Anxiety—Naltrexone—alcohol dependence	0.000708	0.0017	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000706	0.00169	CcSEcCtD
Leflunomide—Upper respiratory tract infection—Citalopram—alcohol dependence	0.000706	0.00169	CcSEcCtD
Leflunomide—Thrombocytopenia—Acamprosate—alcohol dependence	0.000705	0.00169	CcSEcCtD
Leflunomide—Tachycardia—Acamprosate—alcohol dependence	0.000703	0.00169	CcSEcCtD
Leflunomide—Discomfort—Naltrexone—alcohol dependence	0.000702	0.00169	CcSEcCtD
Leflunomide—Pollakiuria—Citalopram—alcohol dependence	0.000701	0.00168	CcSEcCtD
Leflunomide—Skin disorder—Acamprosate—alcohol dependence	0.0007	0.00168	CcSEcCtD
Leflunomide—Hyperhidrosis—Acamprosate—alcohol dependence	0.000696	0.00167	CcSEcCtD
Leflunomide—Dry mouth—Naltrexone—alcohol dependence	0.000695	0.00167	CcSEcCtD
Leflunomide—Weight decreased—Citalopram—alcohol dependence	0.000687	0.00165	CcSEcCtD
Leflunomide—Anorexia—Acamprosate—alcohol dependence	0.000687	0.00165	CcSEcCtD
Leflunomide—Hyperglycaemia—Citalopram—alcohol dependence	0.000685	0.00164	CcSEcCtD
Leflunomide—Anaphylactic shock—Naltrexone—alcohol dependence	0.000681	0.00164	CcSEcCtD
Leflunomide—Pneumonia—Citalopram—alcohol dependence	0.000681	0.00163	CcSEcCtD
Leflunomide—Infection—Naltrexone—alcohol dependence	0.000677	0.00162	CcSEcCtD
Leflunomide—Infestation NOS—Citalopram—alcohol dependence	0.000677	0.00162	CcSEcCtD
Leflunomide—Infestation—Citalopram—alcohol dependence	0.000677	0.00162	CcSEcCtD
Leflunomide—Hypotension—Acamprosate—alcohol dependence	0.000673	0.00161	CcSEcCtD
Leflunomide—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.000671	0.00161	CcSEcCtD
Leflunomide—Nervous system disorder—Naltrexone—alcohol dependence	0.000668	0.0016	CcSEcCtD
Leflunomide—Tachycardia—Naltrexone—alcohol dependence	0.000665	0.0016	CcSEcCtD
Leflunomide—CYP2C9—Biological oxidations—ADH6—alcohol dependence	0.000664	0.00514	CbGpPWpGaD
Leflunomide—Neuropathy peripheral—Citalopram—alcohol dependence	0.000664	0.00159	CcSEcCtD
Leflunomide—Skin disorder—Naltrexone—alcohol dependence	0.000662	0.00159	CcSEcCtD
Leflunomide—Jaundice—Citalopram—alcohol dependence	0.00066	0.00158	CcSEcCtD
Leflunomide—Stomatitis—Citalopram—alcohol dependence	0.00066	0.00158	CcSEcCtD
Leflunomide—Hyperhidrosis—Naltrexone—alcohol dependence	0.000659	0.00158	CcSEcCtD
Leflunomide—Conjunctivitis—Citalopram—alcohol dependence	0.000658	0.00158	CcSEcCtD
Leflunomide—Urinary tract infection—Citalopram—alcohol dependence	0.000658	0.00158	CcSEcCtD
Leflunomide—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000657	0.00508	CbGpPWpGaD
Leflunomide—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000656	0.00157	CcSEcCtD
Leflunomide—Insomnia—Acamprosate—alcohol dependence	0.000651	0.00156	CcSEcCtD
Leflunomide—Anorexia—Naltrexone—alcohol dependence	0.00065	0.00156	CcSEcCtD
Leflunomide—Paraesthesia—Acamprosate—alcohol dependence	0.000647	0.00155	CcSEcCtD
Leflunomide—Haematuria—Citalopram—alcohol dependence	0.000646	0.00155	CcSEcCtD
Leflunomide—Dyspnoea—Acamprosate—alcohol dependence	0.000642	0.00154	CcSEcCtD
Leflunomide—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.00064	0.00495	CbGpPWpGaD
Leflunomide—Hepatobiliary disease—Citalopram—alcohol dependence	0.00064	0.00154	CcSEcCtD
Leflunomide—Epistaxis—Citalopram—alcohol dependence	0.000639	0.00153	CcSEcCtD
Leflunomide—Sinusitis—Citalopram—alcohol dependence	0.000635	0.00152	CcSEcCtD
Leflunomide—Dyspepsia—Acamprosate—alcohol dependence	0.000634	0.00152	CcSEcCtD
Leflunomide—Agranulocytosis—Citalopram—alcohol dependence	0.000632	0.00152	CcSEcCtD
Leflunomide—Decreased appetite—Acamprosate—alcohol dependence	0.000626	0.0015	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000622	0.00149	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000621	0.00149	CcSEcCtD
Leflunomide—Insomnia—Naltrexone—alcohol dependence	0.000616	0.00148	CcSEcCtD
Leflunomide—Pain—Acamprosate—alcohol dependence	0.000616	0.00148	CcSEcCtD
Leflunomide—Constipation—Acamprosate—alcohol dependence	0.000616	0.00148	CcSEcCtD
Leflunomide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000615	0.00475	CbGpPWpGaD
Leflunomide—Paraesthesia—Naltrexone—alcohol dependence	0.000612	0.00147	CcSEcCtD
Leflunomide—Haemoglobin—Citalopram—alcohol dependence	0.000611	0.00147	CcSEcCtD
Leflunomide—Rhinitis—Citalopram—alcohol dependence	0.000609	0.00146	CcSEcCtD
Leflunomide—Hepatitis—Citalopram—alcohol dependence	0.000608	0.00146	CcSEcCtD
Leflunomide—Haemorrhage—Citalopram—alcohol dependence	0.000608	0.00146	CcSEcCtD
Leflunomide—Dyspnoea—Naltrexone—alcohol dependence	0.000608	0.00146	CcSEcCtD
Leflunomide—DHODH—Metabolism—MAOB—alcohol dependence	0.000605	0.00468	CbGpPWpGaD
Leflunomide—CYP1A2—Tryptophan metabolism—ALDH2—alcohol dependence	0.000604	0.00467	CbGpPWpGaD
Leflunomide—Pharyngitis—Citalopram—alcohol dependence	0.000603	0.00145	CcSEcCtD
Leflunomide—AHR—Integrated Breast Cancer Pathway—EP300—alcohol dependence	0.000601	0.00465	CbGpPWpGaD
Leflunomide—Urinary tract disorder—Citalopram—alcohol dependence	0.0006	0.00144	CcSEcCtD
Leflunomide—Oedema peripheral—Citalopram—alcohol dependence	0.000599	0.00144	CcSEcCtD
Leflunomide—Connective tissue disorder—Citalopram—alcohol dependence	0.000597	0.00143	CcSEcCtD
Leflunomide—Urethral disorder—Citalopram—alcohol dependence	0.000596	0.00143	CcSEcCtD
Leflunomide—Feeling abnormal—Acamprosate—alcohol dependence	0.000594	0.00142	CcSEcCtD
Leflunomide—Decreased appetite—Naltrexone—alcohol dependence	0.000592	0.00142	CcSEcCtD
Leflunomide—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000589	0.00141	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000588	0.00141	CcSEcCtD
Leflunomide—Fatigue—Naltrexone—alcohol dependence	0.000588	0.00141	CcSEcCtD
Leflunomide—Constipation—Naltrexone—alcohol dependence	0.000583	0.0014	CcSEcCtD
Leflunomide—Pain—Naltrexone—alcohol dependence	0.000583	0.0014	CcSEcCtD
Leflunomide—Erythema multiforme—Citalopram—alcohol dependence	0.000575	0.00138	CcSEcCtD
Leflunomide—CYP1A2—Melatonin metabolism and effects—MAOA—alcohol dependence	0.000574	0.00444	CbGpPWpGaD
Leflunomide—Urticaria—Acamprosate—alcohol dependence	0.000572	0.00137	CcSEcCtD
Leflunomide—Abdominal pain—Acamprosate—alcohol dependence	0.000569	0.00137	CcSEcCtD
Leflunomide—Body temperature increased—Acamprosate—alcohol dependence	0.000569	0.00137	CcSEcCtD
Leflunomide—Eye disorder—Citalopram—alcohol dependence	0.000568	0.00136	CcSEcCtD
Leflunomide—CYP1A2—Biological oxidations—ADH6—alcohol dependence	0.000568	0.00439	CbGpPWpGaD
Leflunomide—Cardiac disorder—Citalopram—alcohol dependence	0.000564	0.00135	CcSEcCtD
Leflunomide—Feeling abnormal—Naltrexone—alcohol dependence	0.000562	0.00135	CcSEcCtD
Leflunomide—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000561	0.00434	CbGpPWpGaD
Leflunomide—CYP1A2—Phase II conjugation—GGT2—alcohol dependence	0.000557	0.00431	CbGpPWpGaD
Leflunomide—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000557	0.00134	CcSEcCtD
Leflunomide—CYP2C9—Biological oxidations—ADH1A—alcohol dependence	0.000551	0.00426	CbGpPWpGaD
Leflunomide—Immune system disorder—Citalopram—alcohol dependence	0.000549	0.00132	CcSEcCtD
Leflunomide—Mediastinal disorder—Citalopram—alcohol dependence	0.000548	0.00131	CcSEcCtD
Leflunomide—Chills—Citalopram—alcohol dependence	0.000545	0.00131	CcSEcCtD
Leflunomide—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000544	0.00421	CbGpPWpGaD
Leflunomide—Arrhythmia—Citalopram—alcohol dependence	0.000543	0.0013	CcSEcCtD
Leflunomide—Urticaria—Naltrexone—alcohol dependence	0.000541	0.0013	CcSEcCtD
Leflunomide—Body temperature increased—Naltrexone—alcohol dependence	0.000539	0.00129	CcSEcCtD
Leflunomide—Abdominal pain—Naltrexone—alcohol dependence	0.000539	0.00129	CcSEcCtD
Leflunomide—Alopecia—Citalopram—alcohol dependence	0.000537	0.00129	CcSEcCtD
Leflunomide—Mental disorder—Citalopram—alcohol dependence	0.000532	0.00128	CcSEcCtD
Leflunomide—Hypersensitivity—Acamprosate—alcohol dependence	0.000531	0.00127	CcSEcCtD
Leflunomide—Malnutrition—Citalopram—alcohol dependence	0.000529	0.00127	CcSEcCtD
Leflunomide—Flatulence—Citalopram—alcohol dependence	0.000521	0.00125	CcSEcCtD
Leflunomide—Dysgeusia—Citalopram—alcohol dependence	0.000518	0.00124	CcSEcCtD
Leflunomide—Asthenia—Acamprosate—alcohol dependence	0.000517	0.00124	CcSEcCtD
Leflunomide—DHODH—Metabolism—ALDH2—alcohol dependence	0.000515	0.00398	CbGpPWpGaD
Leflunomide—Back pain—Citalopram—alcohol dependence	0.000512	0.00123	CcSEcCtD
Leflunomide—Pruritus—Acamprosate—alcohol dependence	0.00051	0.00122	CcSEcCtD
Leflunomide—Muscle spasms—Citalopram—alcohol dependence	0.000509	0.00122	CcSEcCtD
Leflunomide—ABCG2—HIF-2-alpha transcription factor network—EP300—alcohol dependence	0.000506	0.00391	CbGpPWpGaD
Leflunomide—Hypersensitivity—Naltrexone—alcohol dependence	0.000502	0.0012	CcSEcCtD
Leflunomide—Vision blurred—Citalopram—alcohol dependence	0.000499	0.0012	CcSEcCtD
Leflunomide—Diarrhoea—Acamprosate—alcohol dependence	0.000493	0.00118	CcSEcCtD
Leflunomide—Ill-defined disorder—Citalopram—alcohol dependence	0.000491	0.00118	CcSEcCtD
Leflunomide—Anaemia—Citalopram—alcohol dependence	0.000489	0.00117	CcSEcCtD
Leflunomide—Asthenia—Naltrexone—alcohol dependence	0.000489	0.00117	CcSEcCtD
Leflunomide—CYP2C9—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000485	0.00375	CbGpPWpGaD
Leflunomide—Angioedema—Citalopram—alcohol dependence	0.000483	0.00116	CcSEcCtD
Leflunomide—CYP1A2—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000483	0.00373	CbGpPWpGaD
Leflunomide—Pruritus—Naltrexone—alcohol dependence	0.000482	0.00116	CcSEcCtD
Leflunomide—AHR—Circadian rythm related genes—EP300—alcohol dependence	0.000478	0.0037	CbGpPWpGaD
Leflunomide—Malaise—Citalopram—alcohol dependence	0.000477	0.00114	CcSEcCtD
Leflunomide—Dizziness—Acamprosate—alcohol dependence	0.000476	0.00114	CcSEcCtD
Leflunomide—Vertigo—Citalopram—alcohol dependence	0.000475	0.00114	CcSEcCtD
Leflunomide—Leukopenia—Citalopram—alcohol dependence	0.000474	0.00114	CcSEcCtD
Leflunomide—CYP1A2—Biological oxidations—ADH1A—alcohol dependence	0.00047	0.00364	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—ADH4—alcohol dependence	0.000468	0.00362	CbGpPWpGaD
Leflunomide—Palpitations—Citalopram—alcohol dependence	0.000468	0.00112	CcSEcCtD
Leflunomide—Diarrhoea—Naltrexone—alcohol dependence	0.000466	0.00112	CcSEcCtD
Leflunomide—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000465	0.0036	CbGpPWpGaD
Leflunomide—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000463	0.00358	CbGpPWpGaD
Leflunomide—Cough—Citalopram—alcohol dependence	0.000462	0.00111	CcSEcCtD
Leflunomide—Vomiting—Acamprosate—alcohol dependence	0.000458	0.0011	CcSEcCtD
Leflunomide—Hypertension—Citalopram—alcohol dependence	0.000457	0.0011	CcSEcCtD
Leflunomide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000457	0.00353	CbGpPWpGaD
Leflunomide—Rash—Acamprosate—alcohol dependence	0.000454	0.00109	CcSEcCtD
Leflunomide—Dermatitis—Acamprosate—alcohol dependence	0.000454	0.00109	CcSEcCtD
Leflunomide—Headache—Acamprosate—alcohol dependence	0.000451	0.00108	CcSEcCtD
Leflunomide—Dizziness—Naltrexone—alcohol dependence	0.000451	0.00108	CcSEcCtD
Leflunomide—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000451	0.00349	CbGpPWpGaD
Leflunomide—Chest pain—Citalopram—alcohol dependence	0.00045	0.00108	CcSEcCtD
Leflunomide—Arthralgia—Citalopram—alcohol dependence	0.00045	0.00108	CcSEcCtD
Leflunomide—Myalgia—Citalopram—alcohol dependence	0.00045	0.00108	CcSEcCtD
Leflunomide—Anxiety—Citalopram—alcohol dependence	0.000449	0.00108	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000447	0.00107	CcSEcCtD
Leflunomide—Discomfort—Citalopram—alcohol dependence	0.000445	0.00107	CcSEcCtD
Leflunomide—Dry mouth—Citalopram—alcohol dependence	0.000441	0.00106	CcSEcCtD
Leflunomide—DHODH—Metabolism—GOT2—alcohol dependence	0.000438	0.00339	CbGpPWpGaD
Leflunomide—Vomiting—Naltrexone—alcohol dependence	0.000433	0.00104	CcSEcCtD
Leflunomide—Anaphylactic shock—Citalopram—alcohol dependence	0.000432	0.00104	CcSEcCtD
Leflunomide—Rash—Naltrexone—alcohol dependence	0.00043	0.00103	CcSEcCtD
Leflunomide—Dermatitis—Naltrexone—alcohol dependence	0.000429	0.00103	CcSEcCtD
Leflunomide—Infection—Citalopram—alcohol dependence	0.000429	0.00103	CcSEcCtD
Leflunomide—Nausea—Acamprosate—alcohol dependence	0.000428	0.00103	CcSEcCtD
Leflunomide—Headache—Naltrexone—alcohol dependence	0.000427	0.00102	CcSEcCtD
Leflunomide—Nervous system disorder—Citalopram—alcohol dependence	0.000423	0.00102	CcSEcCtD
Leflunomide—Thrombocytopenia—Citalopram—alcohol dependence	0.000423	0.00101	CcSEcCtD
Leflunomide—Tachycardia—Citalopram—alcohol dependence	0.000421	0.00101	CcSEcCtD
Leflunomide—Skin disorder—Citalopram—alcohol dependence	0.000419	0.00101	CcSEcCtD
Leflunomide—Hyperhidrosis—Citalopram—alcohol dependence	0.000417	0.001	CcSEcCtD
Leflunomide—CYP1A2—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000414	0.00321	CbGpPWpGaD
Leflunomide—Anorexia—Citalopram—alcohol dependence	0.000412	0.000988	CcSEcCtD
Leflunomide—DHODH—Metabolism—CYP2E1—alcohol dependence	0.000411	0.00318	CbGpPWpGaD
Leflunomide—Nausea—Naltrexone—alcohol dependence	0.000405	0.000971	CcSEcCtD
Leflunomide—Hypotension—Citalopram—alcohol dependence	0.000403	0.000968	CcSEcCtD
Leflunomide—CYP1A2—Biological oxidations—ADH4—alcohol dependence	0.0004	0.00309	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—ADH7—alcohol dependence	0.000398	0.00308	CbGpPWpGaD
Leflunomide—CYP1A2—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000396	0.00306	CbGpPWpGaD
Leflunomide—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000393	0.000944	CcSEcCtD
Leflunomide—Insomnia—Citalopram—alcohol dependence	0.000391	0.000937	CcSEcCtD
Leflunomide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.00039	0.00302	CbGpPWpGaD
Leflunomide—Paraesthesia—Citalopram—alcohol dependence	0.000388	0.00093	CcSEcCtD
Leflunomide—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000385	0.00298	CbGpPWpGaD
Leflunomide—Dyspnoea—Citalopram—alcohol dependence	0.000385	0.000924	CcSEcCtD
Leflunomide—CYP2C9—Biological oxidations—GGT2—alcohol dependence	0.000382	0.00295	CbGpPWpGaD
Leflunomide—Dyspepsia—Citalopram—alcohol dependence	0.00038	0.000912	CcSEcCtD
Leflunomide—DHODH—Metabolism—GGT1—alcohol dependence	0.000378	0.00292	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—GOT1—alcohol dependence	0.000378	0.00292	CbGpPWpGaD
Leflunomide—Decreased appetite—Citalopram—alcohol dependence	0.000375	0.000901	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000373	0.000894	CcSEcCtD
Leflunomide—Fatigue—Citalopram—alcohol dependence	0.000372	0.000893	CcSEcCtD
Leflunomide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.00037	0.00286	CbGpPWpGaD
Leflunomide—Pain—Citalopram—alcohol dependence	0.000369	0.000886	CcSEcCtD
Leflunomide—Constipation—Citalopram—alcohol dependence	0.000369	0.000886	CcSEcCtD
Leflunomide—Feeling abnormal—Citalopram—alcohol dependence	0.000356	0.000854	CcSEcCtD
Leflunomide—Gastrointestinal pain—Citalopram—alcohol dependence	0.000353	0.000847	CcSEcCtD
Leflunomide—CYP2C9—Biological oxidations—ADH1B—alcohol dependence	0.000349	0.0027	CbGpPWpGaD
Leflunomide—Urticaria—Citalopram—alcohol dependence	0.000343	0.000823	CcSEcCtD
Leflunomide—Body temperature increased—Citalopram—alcohol dependence	0.000341	0.000819	CcSEcCtD
Leflunomide—Abdominal pain—Citalopram—alcohol dependence	0.000341	0.000819	CcSEcCtD
Leflunomide—CYP1A2—Biological oxidations—ADH7—alcohol dependence	0.00034	0.00263	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—MAOA—alcohol dependence	0.000339	0.00262	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—GGT2—alcohol dependence	0.000326	0.00252	CbGpPWpGaD
Leflunomide—Hypersensitivity—Citalopram—alcohol dependence	0.000318	0.000763	CcSEcCtD
Leflunomide—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000316	0.00245	CbGpPWpGaD
Leflunomide—Asthenia—Citalopram—alcohol dependence	0.00031	0.000743	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—OPRK1—alcohol dependence	0.000307	0.00237	CbGpPWpGaD
Leflunomide—Pruritus—Citalopram—alcohol dependence	0.000305	0.000733	CcSEcCtD
Leflunomide—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000304	0.00236	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—ADH1B—alcohol dependence	0.000298	0.00231	CbGpPWpGaD
Leflunomide—ABCG2—HIF-1-alpha transcription factor network—EP300—alcohol dependence	0.000298	0.0023	CbGpPWpGaD
Leflunomide—Diarrhoea—Citalopram—alcohol dependence	0.000295	0.000709	CcSEcCtD
Leflunomide—CYP2C9—Biological oxidations—MAOB—alcohol dependence	0.000289	0.00224	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000288	0.00223	CbGpPWpGaD
Leflunomide—Dizziness—Citalopram—alcohol dependence	0.000286	0.000685	CcSEcCtD
Leflunomide—PTK2B—Immune System—WASF2—alcohol dependence	0.000284	0.0022	CbGpPWpGaD
Leflunomide—Vomiting—Citalopram—alcohol dependence	0.000275	0.000659	CcSEcCtD
Leflunomide—PTK2B—Immune System—WASF1—alcohol dependence	0.000272	0.00211	CbGpPWpGaD
Leflunomide—Rash—Citalopram—alcohol dependence	0.000272	0.000653	CcSEcCtD
Leflunomide—Dermatitis—Citalopram—alcohol dependence	0.000272	0.000653	CcSEcCtD
Leflunomide—Headache—Citalopram—alcohol dependence	0.000271	0.000649	CcSEcCtD
Leflunomide—CYP1A2—Phase II conjugation—GGT1—alcohol dependence	0.000264	0.00204	CbGpPWpGaD
Leflunomide—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.00026	0.00201	CbGpPWpGaD
Leflunomide—Nausea—Citalopram—alcohol dependence	0.000256	0.000615	CcSEcCtD
Leflunomide—CYP1A2—Biological oxidations—MAOB—alcohol dependence	0.000247	0.00191	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—ALDH2—alcohol dependence	0.000246	0.0019	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000245	0.00189	CbGpPWpGaD
Leflunomide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000245	0.00189	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ADH6—alcohol dependence	0.000225	0.00174	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—POMC—alcohol dependence	0.00022	0.00171	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—ALDH2—alcohol dependence	0.00021	0.00163	CbGpPWpGaD
Leflunomide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000209	0.00162	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—OPRD1—alcohol dependence	0.000206	0.00159	CbGpPWpGaD
Leflunomide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000198	0.00153	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PDYN—alcohol dependence	0.000198	0.00153	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—CYP2E1—alcohol dependence	0.000197	0.00152	CbGpPWpGaD
Leflunomide—CYP2C9—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000194	0.0015	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ADH1A—alcohol dependence	0.000186	0.00144	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—WASF2—alcohol dependence	0.000184	0.00142	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CRHR1—alcohol dependence	0.000184	0.00142	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—GGT1—alcohol dependence	0.00018	0.0014	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—WASF1—alcohol dependence	0.000176	0.00136	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CHRM2—alcohol dependence	0.000173	0.00134	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	0.000171	0.00133	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	0.000171	0.00133	CbGpPWpGaD
Leflunomide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000169	0.00131	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—CYP2E1—alcohol dependence	0.000168	0.0013	CbGpPWpGaD
Leflunomide—CYP1A2—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000166	0.00128	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—MAOA—alcohol dependence	0.000162	0.00125	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—OPRM1—alcohol dependence	0.000159	0.00123	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ADH4—alcohol dependence	0.000159	0.00123	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—GGT1—alcohol dependence	0.000154	0.00119	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—EP300—alcohol dependence	0.000146	0.00113	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NPY—alcohol dependence	0.000146	0.00113	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—HTR1B—alcohol dependence	0.000141	0.00109	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CRH—alcohol dependence	0.000141	0.00109	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000138	0.00107	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—MAOA—alcohol dependence	0.000138	0.00107	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ADH7—alcohol dependence	0.000135	0.00104	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GGT2—alcohol dependence	0.000129	0.001	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—DRD4—alcohol dependence	0.000123	0.000952	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ADH1B—alcohol dependence	0.000118	0.000914	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CNR1—alcohol dependence	0.000118	0.000909	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—DRD2—alcohol dependence	0.000115	0.000887	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—HTR7—alcohol dependence	0.000115	0.000887	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—AVP—alcohol dependence	0.000115	0.000886	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ADH6—alcohol dependence	0.000114	0.000879	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—POMC—alcohol dependence	0.000105	0.000815	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—MAOB—alcohol dependence	9.79e-05	0.000758	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ADH6—alcohol dependence	9.71e-05	0.000751	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—AVP—alcohol dependence	9.65e-05	0.000747	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ADH1A—alcohol dependence	9.42e-05	0.000728	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—POMC—alcohol dependence	9e-05	0.000696	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ALDH2—alcohol dependence	8.33e-05	0.000644	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ADH1A—alcohol dependence	8.05e-05	0.000622	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—HTR2A—alcohol dependence	8.03e-05	0.000621	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ADH4—alcohol dependence	8.01e-05	0.000619	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GOT2—alcohol dependence	7.08e-05	0.000548	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	6.93e-05	0.000536	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ADH4—alcohol dependence	6.84e-05	0.000529	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ADH7—alcohol dependence	6.81e-05	0.000527	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CYP2E1—alcohol dependence	6.66e-05	0.000515	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—EP300—alcohol dependence	6.58e-05	0.000509	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GGT2—alcohol dependence	6.53e-05	0.000505	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—POMC—alcohol dependence	6.41e-05	0.000496	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GGT1—alcohol dependence	6.11e-05	0.000473	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GOT1—alcohol dependence	6.11e-05	0.000473	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ADH1B—alcohol dependence	5.97e-05	0.000462	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	5.92e-05	0.000458	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ADH7—alcohol dependence	5.82e-05	0.00045	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GGT2—alcohol dependence	5.58e-05	0.000431	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—MAOA—alcohol dependence	5.48e-05	0.000424	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ADH1B—alcohol dependence	5.1e-05	0.000395	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—MAOB—alcohol dependence	4.95e-05	0.000383	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—EP300—alcohol dependence	4.25e-05	0.000329	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—MAOB—alcohol dependence	4.23e-05	0.000327	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ALDH2—alcohol dependence	4.21e-05	0.000325	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	4.04e-05	0.000313	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ALDH2—alcohol dependence	3.59e-05	0.000278	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GOT2—alcohol dependence	3.58e-05	0.000277	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—POMC—alcohol dependence	3.57e-05	0.000276	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	3.46e-05	0.000267	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CYP2E1—alcohol dependence	3.36e-05	0.00026	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GGT1—alcohol dependence	3.09e-05	0.000239	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GOT1—alcohol dependence	3.09e-05	0.000239	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GOT2—alcohol dependence	3.06e-05	0.000236	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CYP2E1—alcohol dependence	2.87e-05	0.000222	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—MAOA—alcohol dependence	2.77e-05	0.000214	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.68e-05	0.000208	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GGT1—alcohol dependence	2.64e-05	0.000204	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GOT1—alcohol dependence	2.64e-05	0.000204	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—EP300—alcohol dependence	2.37e-05	0.000183	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—MAOA—alcohol dependence	2.36e-05	0.000183	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.29e-05	0.000177	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—POMC—alcohol dependence	1.8e-05	0.000139	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—POMC—alcohol dependence	1.54e-05	0.000119	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—EP300—alcohol dependence	1.19e-05	9.24e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—EP300—alcohol dependence	1.02e-05	7.9e-05	CbGpPWpGaD
